Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones

2025.12.01 22:18

I'm PortAI, I can summarize articles.

Charles River Laboratories International Inc. (CRL) shares fell 1.15% to $176.09 on Monday, underperforming compared to some competitors. The S&P 500 Index and Dow Jones Industrial Average also declined. CRL is 13.26% below its 52-week high of $203.01. Competitors showed mixed results: Labcorp Holdings Inc. fell 0.39%, Alnylam Pharmaceuticals Inc. rose 0.74%, and Bio-Techne Corp. fell 1.16%. Data compiled on December 1, 2025.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Charles River Laboratories International Inc. (CRL) slipped 1.15% to $176.09 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. This was the stock's second consecutive day of losses. Charles River Laboratories International Inc. closed 13.26% below its 52-week high of $203.01, which the company achieved on December 2nd. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Labcorp Holdings Inc. (LH) fell 0.39% to $267.73, Alnylam Pharmaceuticals Inc. (ALNY) rose 0.74% to $454.56, and Bio-Techne Corp. (TECH) fell 1.16% to $63.76. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1718ET